Approval Summary for Bortezomib for Injection in the Treatment of Multiple Myeloma
Top Cited Papers
Open Access
- 15 June 2004
- journal article
- clinical trial
- Published by American Association for Cancer Research (AACR) in Clinical Cancer Research
- Vol. 10 (12) , 3954-3964
- https://doi.org/10.1158/1078-0432.ccr-03-0781
Abstract
No abstract availableThis publication has 44 references indexed in Scilit:
- Single versus Double Autologous Stem-Cell Transplantation for Multiple MyelomaNew England Journal of Medicine, 2003
- Thalidomide as initial therapy for early-stage myelomaLeukemia, 2003
- Response Rate, Durability of Response, and Survival After Thalidomide Therapy for Relapsed Multiple MyelomaMayo Clinic Proceedings, 2003
- Thalidomide Alone or With Dexamethasone for Previously Untreated Multiple MyelomaJournal of Clinical Oncology, 2003
- Ethanol withdrawal induced CYP2E1 degradation in vivo, blocked by proteasomal inhibitor PS-341Free Radical Biology & Medicine, 2002
- Remission status defined by immunofixation vs. electrophoresis after autologous transplantation has a major impact on the outcome of multiple myeloma patientsBritish Journal of Haematology, 2000
- Antitumor Activity of Thalidomide in Refractory Multiple MyelomaNew England Journal of Medicine, 1999
- CRITERIA FOR EVALUATING DISEASE RESPONSE AND PROGRESSION IN PATIENTS WITH MULTIPLE MYELOMA TREATED BY HIGH‐DOSE THERAPY AND HAEMOPOIETIC STEM CELL TRANSPLANTATIONBritish Journal of Haematology, 1998
- Structural and functional effects of PA700 and modulator protein on proteasomes 1 1Edited by W. BaumeisterJournal of Molecular Biology, 1997
- PA28 Activator Protein Forms Regulatory Caps on Proteasome Stacked RingsJournal of Molecular Biology, 1994